These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 25943910)
1. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis. Liu W; Zhou JG; Sun Y; Zhang L; Xing BC J Gastrointest Surg; 2015 Jul; 19(7):1271-80. PubMed ID: 25943910 [TBL] [Abstract][Full Text] [Related]
2. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Qi X; Wang D; Su C; Li H; Guo X Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835 [TBL] [Abstract][Full Text] [Related]
3. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. Yang B; Zheng B; Yang M; Zeng Z; Yang F; Pu J; Li C; Liao Z Hepatol Int; 2018 Sep; 12(5):417-428. PubMed ID: 30073454 [TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396 [TBL] [Abstract][Full Text] [Related]
5. Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis. Liang L; Xing H; Zhang H; Zhong J; Li C; Lau WY; Wu M; Shen F; Yang T HPB (Oxford); 2018 Feb; 20(2):110-119. PubMed ID: 29174493 [TBL] [Abstract][Full Text] [Related]
6. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Jianyong L; Lunan Y; Wentao W; Yong Z; Bo L; Tianfu W; Minqing X; Jiaying Y Medicine (Baltimore); 2014 Nov; 93(26):e180. PubMed ID: 25474433 [TBL] [Abstract][Full Text] [Related]
7. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Qi X; Liu L; Wang D; Li H; Su C; Guo X Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695 [TBL] [Abstract][Full Text] [Related]
9. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898 [TBL] [Abstract][Full Text] [Related]
10. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan. Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546 [TBL] [Abstract][Full Text] [Related]
11. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma. Zhang DZ; Wei XD; Wang XP World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473 [TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma. Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909 [TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. Han K; Kim JH World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949 [TBL] [Abstract][Full Text] [Related]
15. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study. Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917 [TBL] [Abstract][Full Text] [Related]
16. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis. Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740 [TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of hepatic resection versus transarterial chemoembolization for solitary large hepatocellular carcinoma. Stevens CL; Awad A; Abbas SM; Watters DAK HPB (Oxford); 2017 Aug; 19(8):653-658. PubMed ID: 28427829 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810 [TBL] [Abstract][Full Text] [Related]
19. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620 [TBL] [Abstract][Full Text] [Related]
20. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. Zhong JH; Xiang BD; Gong WF; Ke Y; Mo QG; Ma L; Liu X; Li LQ PLoS One; 2013; 8(7):e68193. PubMed ID: 23874536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]